Optogenetics for Retinitis Pigmentosa

ReMedys has decided to accompany, on the path towards the clinic, a highly innovative project; optogenetics for the treatment of Retinitis Pigmentosa, RP, a group of severe eye disorders that cause progressive vision loss (https://ghr.nlm.nih.gov/condition/retinitis-pigmentosa & http://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1002143).

ReMedys will be working to secure all the R&D support for bringing, this potential therapeutic solution, closer to RP patients.

A potential clinical entry is planned for 2019.